Amylyx Pharmaceuticals(AMLX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

AMLX Amylyx Pharmaceuticals

Pre-Mkt 04-13 08:42:38 EDT

16.36

-0.96

-5.54%

盘前16.36

+0.000.00%

08:33 EDT

High17.36	Low16.34	Vol851.40K
Open17.36	D1 Closing17.32	Amplitude5.89%
Mkt Cap1.81B	Tradable Cap1.07B	Total Shares110.54M
T/O14.22M	T/O Rate1.30%	Tradable Shares65.45M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"AMLX","market":"US","secType":"STK","nameCN":"Amylyx Pharmaceuticals","latestPrice":16.36,"timestamp":1775851200000,"preClose":17.32,"halted":0,"volume":851397,"hourTrading":{"tag":"盘前","latestPrice":16.36,"preClose":16.36,"latestTime":"08:33 EDT","volume":74,"amount":1204.7599599999999,"timestamp":1776083599271,"change":0,"changeRate":0,"amplitude":0.032396},"delay":0,"changeRate":-0.05542725173210167,"floatShares":65449399,"shares":110536944,"eps":-1.530525,"marketStatus":"Pre-Mkt","change":-0.96,"latestTime":"04-13 08:42:38 EDT","open":17.36,"high":17.36,"low":16.34,"amount":14218006.36914,"amplitude":0.058891,"askPrice":17.12,"askSize":5,"bidPrice":13.08,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.530525,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1776087000000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1641531600000,"exchange":"NASDAQ","adjPreClose":16.36,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":16.36,"preClose":16.36,"latestTime":"08:33 EDT","volume":74,"amount":1204.7599599999999,"timestamp":1776083599271,"change":0,"changeRate":0,"amplitude":0.032396},"postHourTrading":{"tag":"盘后","latestPrice":16.15,"preClose":16.36,"latestTime":"19:52 EDT","volume":23826,"amount":390739.3805,"timestamp":1775865128862,"change":-0.21,"changeRate":-0.012836,"amplitude":0.012836},"volumeRatio":0.5386903101497587,"impliedVol":0.4291,"impliedVolPercentile":0.3092},"requestUrl":"/m/hq/s/AMLX/tweets","defaultTab":"tweets","newsList":[{"id":"2625941741","title":"Amylyx to present at Needham Virtual Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2625941741","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625941741?lang=en_us&edition=fundamental","pubTime":"2026-04-08 21:00","pubTimestamp":1775653234,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals management will present at Needham 25th Annual Virtual Healthcare Conference on April 15, 2026 at 8:45 a.m. ET.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amylyx Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire  on April 08, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nNDL8zjkG7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AMLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625966981","title":"A Look At Amylyx Pharmaceuticals (AMLX) Valuation As Avexitide Hits A Key Phase 3 LUCIDITY Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=2625966981","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625966981?lang=en_us&edition=fundamental","pubTime":"2026-04-07 09:26","pubTimestamp":1775525188,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals (AMLX) shares are in focus after the company reported that the final participant has been randomized and dosed in LUCIDITY, its pivotal Phase 3 trial of avexitide for post-bariatric hypoglycemia.\nSee our latest analysis for Amylyx Pharmaceuticals.\nThe latest trial milestone arrives as momentum in Amylyx Pharmaceuticals' share price has been building, with a 7 day share price return of 23.98% and a 90 day share price return of 39.02%, set against a very large 1 year...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amlx/amylyx-pharmaceuticals/news/a-look-at-amylyx-pharmaceuticals-amlx-valuation-as-avexitide","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amlx/amylyx-pharmaceuticals/news/a-look-at-amylyx-pharmaceuticals-amlx-valuation-as-avexitide","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","AMLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622273030","title":"Amylyx Pharmaceuticals Price Target Maintained With a $34.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2622273030","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622273030?lang=en_us&edition=fundamental","pubTime":"2026-03-25 18:45","pubTimestamp":1774435500,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AMLX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 25, 2026 06:45 ET (10:45 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AMLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621060370","title":"Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday Amid Economic Data Releases","url":"https://stock-news.laohu8.com/highlight/detail?id=2621060370","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621060370?lang=en_us&edition=fundamental","pubTime":"2026-03-24 21:13","pubTimestamp":1774358023,"startTime":"0","endTime":"0","summary":"The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) retreated by 0.2% and the actively traded Invesco QQQ Trust (QQQ) was 0.2% lower in Tuesday's premarket activity amid economic data r","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IYK","BITO","IBB","XLP","SPY.AU","UNG","VHT","SMFG","FAS","FAZ","RTH","XLF","XLY","SPY","AMLX","VHT.AU","VIS","IYH","LI","BETH","VDC","IGV","XRT","XLK","SOXX",".DJI","CDLR","EQR","IYJ","XLV","IYW","JEF","QQQ","EETH","IVV","IYE","RTH.AU","XLI","XSD","IPK","IGM","EXI","BORR"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2621069135","title":"Amylyx completes enrollment in Phase 3 Lucidity trial of avexitide","url":"https://stock-news.laohu8.com/highlight/detail?id=2621069135","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621069135?lang=en_us&edition=fundamental","pubTime":"2026-03-24 19:05","pubTimestamp":1774350357,"startTime":"0","endTime":"0","summary":"Amylyx (AMLX) Pharmaceuticals announced that the last participant has been randomized and dosed in the Phase 3 Lucidity clinical trial of avexitide...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amylyx-completes-enrollment-in-phase-3-lucidity-trial-of-avexitide-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amylyx-completes-enrollment-in-phase-3-lucidity-trial-of-avexitide-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","AMLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621066464","title":"Amylyx completes enrollment of 78 participants in Phase 3 LUCIDITY trial of avexitide in post-bariatric hypoglycemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2621066464","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621066464?lang=en_us&edition=fundamental","pubTime":"2026-03-24 19:00","pubTimestamp":1774350026,"startTime":"0","endTime":"0","summary":"Amylyx reported completion of enrollment in the Phase 3 LUCIDITY trial evaluating avexitide for post-bariatric hypoglycemia after Roux-en-Y gastric bypass surgery.The randomized, double-blind, placebo-controlled study is 16 weeks long and enrolled 78 participants.The primary endpoint is reduction in the composite of Level 2 and Level 3 hypoglycemic events through Week 16.Topline results have not yet been presented and are expected in Q3 2026.Participants who complete the double-blind period may enter a 32-week open-label extension.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amylyx Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire  on March 24, 2026, and is solely responsible for ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nNDL4sXrBv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMLX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621462066","title":"Amylyx Pharmaceuticals Announces Completion of Enrollment in Pivotal Phase 3 Lucidity Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2621462066","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621462066?lang=en_us&edition=fundamental","pubTime":"2026-03-24 19:00","pubTimestamp":1774350000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nTUA4BDZZS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AMLX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621066437","title":"Amylyx Pharmaceuticals Inc - Topline Data Readout for Lucidity Trial Anticipated in Q3 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2621066437","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621066437?lang=en_us&edition=fundamental","pubTime":"2026-03-24 19:00","pubTimestamp":1774350000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nTUA4BDZZS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AMLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620226054","title":"Amylyx Pharmaceuticals Is Maintained at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2620226054","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620226054?lang=en_us&edition=fundamental","pubTime":"2026-03-19 22:00","pubTimestamp":1773928800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AMLX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 19, 2026 10:00 ET (14:00 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AMLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115814310","title":"Stock Track | Amylyx Pharmaceuticals Soars 5.24% Intraday After H.C. Wainwright Raises Price Target to $34","url":"https://stock-news.laohu8.com/highlight/detail?id=1115814310","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115814310?lang=en_us&edition=fundamental","pubTime":"2026-03-05 00:30","pubTimestamp":1772641838,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals' stock soared 5.24% during intraday trading on Wednesday, following a bullish analyst update from H.C. Wainwright.The firm's analyst, Andrew Fein, raised the price target on...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["AMLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617044554","title":"Amylyx Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2617044554","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617044554?lang=en_us&edition=fundamental","pubTime":"2026-03-05 00:12","pubTimestamp":1772640720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AMLX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 04, 2026 11:12 ET (16:12 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMLX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616255956","title":"Amylyx price target raised to $34 from $28 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2616255956","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616255956?lang=en_us&edition=fundamental","pubTime":"2026-03-04 22:38","pubTimestamp":1772635090,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Andrew Fein raised the firm’s price target on Amylyx (AMLX) to $34 from $28 and keeps a Buy rating on the shares. Following...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amylyx-price-target-raised-to-34-from-28-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amylyx-price-target-raised-to-34-from-28-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","AMLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616556795","title":"Amylyx Pharmaceuticals, Inc. : H.c. Wainwright Raises Target Price to $34 From $28","url":"https://stock-news.laohu8.com/highlight/detail?id=2616556795","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616556795?lang=en_us&edition=fundamental","pubTime":"2026-03-04 22:30","pubTimestamp":1772634602,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nAZN4SJJUG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AMLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126914858","title":"Stock Track | Amylyx Pharmaceuticals Plummets 5.52% Intraday Following Shelf Offering Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=1126914858","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126914858?lang=en_us&edition=fundamental","pubTime":"2026-03-03 22:52","pubTimestamp":1772549544,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals' stock plummeted 5.52% during intraday trading on Tuesday, following the company's announcement of a mixed securities shelf offering.The biotechnology firm filed for an...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["AMLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616326279","title":"Amylyx Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2616326279","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616326279?lang=en_us&edition=fundamental","pubTime":"2026-03-03 22:31","pubTimestamp":1772548260,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings SummaryAmylyx Pharmaceuticals Inc AMLX.OQ reported a quarterly adjusted loss of 30 cents per share for the quart","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nL8N3ZR1WK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AMLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616203328","title":"Amylyx files automatic mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2616203328","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616203328?lang=en_us&edition=fundamental","pubTime":"2026-03-03 21:12","pubTimestamp":1772543552,"startTime":"0","endTime":"0","summary":"08:07 EST Amylyx (AMLX) files automatic mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving breakin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amylyx-files-automatic-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amylyx-files-automatic-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","AMLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616834077","title":"Amylyx Pharmaceuticals Inc - Files for Mixed Shelf Offering; Size Not Disclosed - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2616834077","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616834077?lang=en_us&edition=fundamental","pubTime":"2026-03-03 21:02","pubTimestamp":1772542975,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nFWN3ZR0Q0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AMLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616347293","title":"Amylyx reports Q4 EPS (30c), consensus (34c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2616347293","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616347293?lang=en_us&edition=fundamental","pubTime":"2026-03-03 20:37","pubTimestamp":1772541436,"startTime":"0","endTime":"0","summary":"“2025 was a year of meaningful advancement for Amylyx’s (AMLX) pivotal avexitide program in post-bariatric hypoglycemia, as well as progress across...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amylyx-reports-q4-eps-30c-consensus-34c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amylyx-reports-q4-eps-30c-consensus-34c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AMLX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616427173","title":"Earnings Flash (AMLX) Amylyx Pharmaceuticals Posts Q4 Net Loss $0.30 a Share, vs. FactSet Est of $0.29 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2616427173","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616427173?lang=en_us&edition=fundamental","pubTime":"2026-03-03 20:13","pubTimestamp":1772540010,"startTime":"0","endTime":"0","summary":"Earnings Flash (AMLX) Amylyx Pharmaceuticals Posts Q4 Net Loss $0.30 a Share, vs. FactSet Est of $0.29 Loss","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","AMLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616342904","title":"Amylyx Pharmaceuticals Q4 net loss beats estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2616342904","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616342904?lang=en_us&edition=fundamental","pubTime":"2026-03-03 20:08","pubTimestamp":1772539687,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals Q4 net loss beats estimatesOverviewPharmaceutical firm's Q4 loss per share beat analyst expectationsNet loss for Q4 beat analyst estimatesCompany expects cash runway to fund ope","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nL1N3ZR0H2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMLX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.amylyx.com","stockEarnings":[{"period":"1week","weight":0.0943},{"period":"1month","weight":0.0958},{"period":"3month","weight":0.3399},{"period":"6month","weight":0.1473},{"period":"1year","weight":3.6877},{"period":"ytd","weight":0.3543}],"compareEarnings":[{"period":"1week","weight":0.036},{"period":"1month","weight":0.0046},{"period":"3month","weight":-0.021},{"period":"6month","weight":0.0405},{"period":"1year","weight":0.2952},{"period":"ytd","weight":-0.0036}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Amylyx Pharmaceuticals, Inc., a commercial-stage biotechnology company, engages in the discovery and development of treatment for amyotrophic lateral sclerosis (ALS) and neurodegenerative diseases. The company's products include RELYVRIO, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of ALS in adults in the United States and marketed as ALBRIOZA for the treatment of ALS in Canada. It is also developing AMX0114 for other neurodegenerative diseases. Amylyx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.074034},{"month":2,"riseRate":0.6,"avgChangeRate":0.089231},{"month":3,"riseRate":0.2,"avgChangeRate":-0.324118},{"month":4,"riseRate":0.4,"avgChangeRate":-0.014769},{"month":5,"riseRate":0.25,"avgChangeRate":-0.046188},{"month":6,"riseRate":0.75,"avgChangeRate":0.347356},{"month":7,"riseRate":1,"avgChangeRate":0.206362},{"month":8,"riseRate":0.5,"avgChangeRate":0.025088},{"month":9,"riseRate":0.75,"avgChangeRate":0.218209},{"month":10,"riseRate":0.75,"avgChangeRate":0.212399},{"month":11,"riseRate":0.75,"avgChangeRate":0.011294},{"month":12,"riseRate":0.25,"avgChangeRate":-0.127185}],"exchange":"NASDAQ","name":"Amylyx Pharmaceuticals","nameEN":"Amylyx Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Amylyx Pharmaceuticals(AMLX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Amylyx Pharmaceuticals(AMLX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Amylyx Pharmaceuticals,AMLX,Amylyx Pharmaceuticals股票,Amylyx Pharmaceuticals股票老虎,Amylyx Pharmaceuticals股票老虎国际,Amylyx Pharmaceuticals行情,Amylyx Pharmaceuticals股票行情,Amylyx Pharmaceuticals股价,Amylyx Pharmaceuticals股市,Amylyx Pharmaceuticals股票价格,Amylyx Pharmaceuticals股票交易,Amylyx Pharmaceuticals股票购买,Amylyx Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Amylyx Pharmaceuticals(AMLX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Amylyx Pharmaceuticals(AMLX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}